<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.45221.013</object-id><label>Table 3.</label><caption><title>Human diseases caused by mutations in NST genes.</title><p>Only point mutations are shown; however, there are many examples of other types of mutations in SLC35 genes (e.g. insertions and deletions) that lead to frameshift or premature truncations that also cause disease (see <xref ref-type="bibr" rid="bib19">Edvardson et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Hiraoka et al., 2007</xref>; <xref ref-type="bibr" rid="bib51">Martinez-Duncker et al., 2005</xref> and Online Mendelian Inheritance in Man (OMIM) database (<ext-link ext-link-type="uri" xlink:href="https://omim.org">https://omim.org</ext-link>)).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Gene</th><th valign="bottom">Disease</th><th valign="bottom">Mutation</th><th valign="bottom">mCST residue</th><th valign="bottom">Biochemical phenotype</th><th valign="bottom">Possible mechanism based on the structure</th><th valign="bottom">Ref.<sup>*</sup></th></tr></thead><tbody><tr><td valign="top">SLC35A1</td><td valign="top">Congenital disorder of glycosylation type IIf</td><td valign="top">Q101H</td><td valign="top"/><td valign="top">CMP-Sia transport activity reduced by 50%.</td><td valign="top">Impairs substrate interaction.</td><td valign="top">1</td></tr><tr><td valign="top">SLC35A1</td><td valign="top">Congenital disorder of glycosylation type IIf</td><td valign="top">T156R</td><td valign="top"/><td valign="top">CMP-Sia transport activity reduced by 9-fold.</td><td valign="top">Impairs conformational transitions during transport.</td><td valign="top">2</td></tr><tr><td valign="top">SLC35A1</td><td valign="top">Congenital disorder of glycosylation type IIf</td><td valign="top">E196K</td><td valign="top"/><td valign="top">CMP-Sia transport activity reduced by 9-fold.</td><td valign="top">Impairs conformational transitions during transport.</td><td valign="top">2</td></tr><tr><td valign="top">SLC35A2</td><td valign="top">Epileptic encephalopathy</td><td valign="top">S213F</td><td valign="top">S188</td><td valign="top">No UDP-Gal transport observed.</td><td valign="top">Impairs substrate interaction.</td><td valign="top">3</td></tr><tr><td valign="top">SLC35A2</td><td valign="top">Congenital disorder of glycosylation type IIm</td><td valign="top">V331I</td><td valign="top">V306</td><td valign="top">UDP-Gal transport reduced by at least 60%.</td><td valign="top">Impairs conformational transitions during transport.</td><td valign="top">4</td></tr><tr><td valign="top">SLC35C1</td><td valign="top">Congenital disorder of glycosylation type IIc</td><td valign="top">R147C</td><td valign="top">Y121</td><td valign="top">Does not rescue fucosylation in cells lacking GDP-fucose transport.</td><td valign="top">Impairs substrate interaction.</td><td valign="top">5, 6</td></tr><tr><td valign="top">SLC35C1</td><td valign="top">Congenital disorder of glycosylation type IIc</td><td valign="top">T308R</td><td valign="top">T284</td><td valign="top">Does not rescue fucosylation in cells lacking GDP-fucose transport.</td><td valign="top">Impairs conformational transitions during transport.</td><td valign="top">6, 7</td></tr><tr><td valign="top">SLC35D1</td><td valign="top">Schneckenbecken dysplasia</td><td valign="top">T65P</td><td valign="top">A38</td><td valign="top">Near-complete loss of transport activity.</td><td valign="top">Impairs conformational transitions during transport.</td><td valign="top">8</td></tr></tbody></table><table-wrap-foot><fn><p>*References: 1 (<xref ref-type="bibr" rid="bib55">Mohamed et al., 2013</xref>), 2 (<xref ref-type="bibr" rid="bib61">Ng et al., 2017</xref>), 3 (<xref ref-type="bibr" rid="bib44">Kodera et al., 2013</xref>), 4 (<xref ref-type="bibr" rid="bib60">Ng et al., 2013</xref>), 5 (<xref ref-type="bibr" rid="bib49">L&#252;hn et al., 2001</xref>), 6 (<xref ref-type="bibr" rid="bib48">L&#252;bke et al., 2001</xref>), 7 (<xref ref-type="bibr" rid="bib23">Etzioni et al., 2002</xref>), 8 (<xref ref-type="bibr" rid="bib29">Furuichi et al., 2009</xref>)</p></fn></table-wrap-foot></table-wrap>